Cargando…
Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949828/ https://www.ncbi.nlm.nih.gov/pubmed/35338114 http://dx.doi.org/10.1038/s41392-022-00942-y |
| _version_ | 1784674996354809856 |
|---|---|
| author | Chen, Xuenian Shi, Tongfei Yang, Chao Chen, Fangman He, Xuan Zhang, Kunbao Hu, Hanze Cai, Lulu Leong, Kam W. Shao, Dan |
| author_facet | Chen, Xuenian Shi, Tongfei Yang, Chao Chen, Fangman He, Xuan Zhang, Kunbao Hu, Hanze Cai, Lulu Leong, Kam W. Shao, Dan |
| author_sort | Chen, Xuenian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8949828 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89498282022-03-25 Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses Chen, Xuenian Shi, Tongfei Yang, Chao Chen, Fangman He, Xuan Zhang, Kunbao Hu, Hanze Cai, Lulu Leong, Kam W. Shao, Dan Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-03-25 /pmc/articles/PMC8949828/ /pubmed/35338114 http://dx.doi.org/10.1038/s41392-022-00942-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Chen, Xuenian Shi, Tongfei Yang, Chao Chen, Fangman He, Xuan Zhang, Kunbao Hu, Hanze Cai, Lulu Leong, Kam W. Shao, Dan Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses |
| title | Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses |
| title_full | Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses |
| title_fullStr | Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses |
| title_full_unstemmed | Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses |
| title_short | Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses |
| title_sort | scalable biomimetic sars-cov‑2 nanovaccines with robust protective immune responses |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949828/ https://www.ncbi.nlm.nih.gov/pubmed/35338114 http://dx.doi.org/10.1038/s41392-022-00942-y |
| work_keys_str_mv | AT chenxuenian scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT shitongfei scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT yangchao scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT chenfangman scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT hexuan scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT zhangkunbao scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT huhanze scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT cailulu scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT leongkamw scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses AT shaodan scalablebiomimeticsarscov2nanovaccineswithrobustprotectiveimmuneresponses |